"Multiple sclerosis (MS) is the most prevalent non-traumatic, disabling neurologic condition among young adults worldwide. The diagnosis and management of MS is complicated, especially in the setting of a recent significant increase in the number of FDA-approved therapies, and a…
Affecting an estimated 2.5 million people worldwide, multiple sclerosis (MS) is the most common neurological cause of debilitation in young adults. Incurable, and with the precise causes still unknown, both diagnosis and management of the condition is complicated. This book summ…
"Multiple sclerosis (MS) is the most prevalent non-traumatic, disabling neurologic condition among young adults worldwide. The diagnosis and management of MS is complicated, especially in the setting of a recent significant increase in the number of FDA-approved therapies, and a…
Affecting an estimated 2.5 million people worldwide, multiple sclerosis (MS) is the most common neurological cause of debilitation in young adults. Incurable, and with the precise causes still unknown, both diagnosis and management of the condition is complicated. This book summ…
"Multiple sclerosis (MS) is the most prevalent non-traumatic, disabling neurologic condition among young adults worldwide. The diagnosis and management of MS are complicated, especially in the setting of a recent significant increase in the number of Food and Drug Association-ap…
"Multiple sclerosis (MS) is the most prevalent non-traumatic, disabling neurologic condition among young adults worldwide. The diagnosis and management of MS is complicated, especially in the setting of a recent significant increase in the number of FDA-approved therapies, and a…